tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
PCRX is currently covered by 11 analysts with an average price target of $34.91. This is a potential upside of $9.17 (35.63%) from yesterday's end of day stock price of $25.74.
Pacira Pharmaceuticals's activity chart (see below) currently has 249 price targets and 244 ratings on display. The stock rating distribution of PCRX is 90.2% BUY, 7.84% HOLD and 1.96% SELL.
Analysts average stock forecasts to be materialized ratio is 69.55% with an average time for these price targets to be met of 307.88 days.
Highest price target for PCRX is $39, Lowest price target is $10, average price target is $34.91.
Most recent stock forecast was given by GREGORY RENZA from RBC on 14-Jan-2025. First documented stock forecast 18-Jan-2013.
Currently out of the existing stock ratings of PCRX, 46 are a BUY (90.2%), 4 are a HOLD (7.84%), 1 are a SELL (1.96%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$18
$-7.44 (-29.25%)
$16
1 months 6 days ago
(14-Jan-2025)
1/10 (10%)
$-2.91 (-13.92%)
11
Buy
$30
$4.56 (17.92%)
$22
1 months 7 days ago
(13-Jan-2025)
4/18 (22.22%)
$9.02 (42.99%)
496
Buy
$39
$13.56 (53.30%)
$39
2 months 16 days ago
(04-Dec-2024)
13/27 (48.15%)
$21.25 (119.72%)
233
Hold
$17
$-8.44 (-33.18%)
$25
3 months 8 days ago
(12-Nov-2024)
4/11 (36.36%)
$0.06 (0.35%)
270
Buy
$37
6 months 8 days ago
(12-Aug-2024)
22/26 (84.62%)
$16.35 (79.18%)
55
What is PCRX (Pacira Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PCRX (Pacira Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PCRX (Pacira Pharmaceuticals)?
Which analyst is the currently most bullish on PCRX (Pacira Pharmaceuticals)?
Which analyst is the currently most reserved on PCRX (Pacira Pharmaceuticals)?
